Giampiero de Luca
Direktor/Vorstandsmitglied bei Auregen Biotherapeutics SA
Aktive Positionen von Giampiero de Luca
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Stallergenes Canada, Inc. | Direktor/Vorstandsmitglied | - | - |
Skylark Bio, Inc.
Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Direktor/Vorstandsmitglied | - | - |
Commave Therapeutics SA
Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Giampiero de Luca
Ehemalige bekannte Positionen von Giampiero de Luca
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STALLERGENES GREER | Direktor/Vorstandsmitglied | 15.03.2021 | 09.06.2022 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | 01.01.1988 | 17.01.2007 |
Ausbildung von Giampiero de Luca
University of Milan | Doctorate Degree |
Statistik
International
Schweiz | 4 |
Italien | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Technology Services |
Commave Therapeutics SA
Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Health Technology |
Skylark Bio, Inc.
Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Commercial Services |
Stallergenes Canada, Inc. | |
Stallergenes Greer Ltd.
Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Giampiero de Luca
- Erfahrung